AAP Grand Rounds Subscribe to Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 14 No. 4, October 2005
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldous, M. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aldous, M. B.
Related Collections
Right arrow Epidemiology

AAP Grand Rounds 14:44-45 (2005)
© 2005 American Academy of Pediatrics

EPIDEMIOLOGY

Follow-Up of Elevated Screening Blood Lead Levels

Source: Kemper AR, Cohn LM, Fant KE, et al. Follow-up testing among children with elevated screening blood lead levels. JAMA. 2005;293:2232–2237.[Abstract/Free Full Text]

The first 20% of the full text of this article appears below.

Among United States children ages 1 year to 5 years, 2.2% have blood lead levels (BLL) over 10 µg/dL.1 The rate of elevated BLL among Medicaid-enrolled children is threefold higher than among other children.2 As a result, federal requirements mandate blood lead screening among Medicaid recipients. The first step in follow-up of an elevated screening BLL is confirmation by repeat screening. Investigators at the University of Michigan, Ann Arbor, and the Michigan Department of Community Health (MDCH), Lansing, studied Michigan Medicaid data to determine the proportion of children with elevated BLL who received follow-up BLL screening within 6 months.

Data from the MDCH, which receives results of all blood lead screenings performed in Michigan laboratories, were linked to Medicaid program files to identify Medicaid-enrolled children ages 6 years and younger with BLL over 10 µg/dL during an 18-month period in 2002 . . . [Full Text of this Article]

Michael B. Aldous, MD, MPH, FAAP
Pediatrics, University of Arizona, Tucson, AZ

 





HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Academy of Pediatrics.